Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wildt

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Annals of the Rheumatic Diseases|January 1, 1996
Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factorA Scheja, A Akesson, I Niewierowicz, et al.
The Journal of Experimental Biology|September 17, 2004
Regulation of serotonin levels by multiple light-entrainable endogenous rhythmsM Wildt, E M Goergen, J L Benton, et al.
Arthritis Research|April 12, 2001
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)A Scheja, A Akesson, P Geborek, et al.
The European Respiratory Journal|November 17, 2006
BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosisA Scheja, K Larsen, L Todorova, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Annals of the Rheumatic Diseases|January 1, 1996
Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factorA Scheja, A Akesson, I Niewierowicz, et al.
The Journal of Experimental Biology|September 17, 2004
Regulation of serotonin levels by multiple light-entrainable endogenous rhythmsM Wildt, E M Goergen, J L Benton, et al.
Arthritis Research|April 12, 2001
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)A Scheja, A Akesson, P Geborek, et al.
The European Respiratory Journal|November 17, 2006
BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosisA Scheja, K Larsen, L Todorova, et al.
Pageof 2